NPORT-EX 2 854265VOYA022924.htm
PORTFOLIO
OF
INVESTMENTS
as
of
February
29,
2024
(Unaudited)
1
Voya
Small
Cap
Growth
Fund
Shares
RA
Value
Percentage
of
Net
Assets
COMMON
STOCK
:
95
.8
%
Consumer
Discretionary
:
15
.3
%
100,823 
(1)
Boot
Barn
Holdings,
Inc.
$
9,326,128
1
.1
233,836 
(1)
Cava
Group,
Inc.
13,658,361
1
.6
169,581 
Churchill
Downs,
Inc.
20,666,836
2
.4
119,415 
(1)
Dave
&
Buster's
Entertainment,
Inc.
7,372,682
0
.9
221,577 
(1)
Dutch
Bros,
Inc.
- Class
A
6,454,538
0
.7
39,159 
(1)
Five
Below,
Inc.
7,858,428
0
.9
67,590 
(1)
Kura
Sushi
USA,
Inc.
- Class
A
6,423,078
0
.7
185,145 
(1)
Modine
Manufacturing
Co.
16,609,358
1
.9
125,542 
Patrick
Industries,
Inc.
15,057,507
1
.8
224,634 
(1)
Skyline
Champion
Corp.
18,822,083
2
.2
82,645 
Strategic
Education,
Inc.
9,156,240
1
.1
131,405,239
15
.3
Energy
:
3
.9
%
593,943 
(1)
Helix
Energy
Solutions
Group,
Inc.
5,345,487
0
.6
42,273 
Matador
Resources
Co.
2,669,540
0
.3
329,454 
Northern
Oil
and
Gas,
Inc.
11,771,391
1
.4
615,674 
Patterson-UTI
Energy,
Inc.
7,123,348
0
.8
65,837 
(1)
Weatherford
International
PLC
6,755,535
0
.8
33,665,301
3
.9
Financials
:
5
.9
%
76,388 
FirstCash
Holdings,
Inc.
8,746,426
1
.0
127,183 
HCI
Group,
Inc.
12,415,604
1
.4
65,891 
(1)
Palomar
Holdings,
Inc.
5,016,941
0
.6
70,562 
Piper
Sandler
Cos.
13,284,708
1
.6
306,732 
(1)
Skyward
Specialty
Insurance
Group,
Inc.
11,223,324
1
.3
50,687,003
5
.9
Health
Care
:
18
.6
%
180,134 
(1)
10X
Genomics,
Inc.
- Class
A
8,401,450
1
.0
87,310 
(1)
ACADIA
Pharmaceuticals,
Inc.
2,029,084
0
.2
95,239 
(1)
Alkermes
PLC
2,827,646
0
.3
171,079 
(1)
Amicus
Therapeutics,
Inc.
2,193,233
0
.3
25,439 
(1)
Arcellx,
Inc.
1,674,395
0
.2
65,816 
(1)
Arrowhead
Pharmaceuticals,
Inc.
2,112,694
0
.2
32,092 
(1)
Blueprint
Medicines
Corp.
3,001,244
0
.4
51,933 
(1)
Bridgebio
Pharma,
Inc.
1,773,512
0
.2
54,226 
(1)
Cytokinetics,
Inc.
3,917,286
0
.5
77,684 
(1)
Denali
Therapeutics,
Inc.
1,536,589
0
.2
Shares
Value
Percentage
of
Net
Assets
COMMON
STOCK:
(continued)
Health
Care:
(continued)
70,359 
Ensign
Group,
Inc.
$
8,789,246
1
.0
246,379 
(1)
Evolent
Health,
Inc.
- Class
A
8,354,712
1
.0
74,377 
(1)
Halozyme
Therapeutics,
Inc.
2,960,948
0
.3
122,846 
(1)
Inari
Medical,
Inc.
5,665,658
0
.7
70,912 
(1)
Insmed,
Inc.
1,965,681
0
.2
53,508 
(1)
Intra-Cellular
Therapies,
Inc.
3,719,876
0
.4
14,152 
(1)
Krystal
Biotech,
Inc.
2,256,819
0
.3
18,287 
(1)
Medpace
Holdings,
Inc.
7,269,448
0
.8
95,255 
(1)
Merit
Medical
Systems,
Inc.
7,258,431
0
.8
291,733 
(1)
Natera,
Inc.
25,231,987
2
.9
259,712 
(1)
Option
Care
Health,
Inc.
8,380,906
1
.0
42,008 
(1)
Repligen
Corp.
8,149,132
1
.0
65,868 
(1)
Revolution
Medicines,
Inc.
1,941,789
0
.2
34,605 
(1)
Rhythm
Pharmaceuticals,
Inc.
1,502,549
0
.2
325,014 
Select
Medical
Holdings
Corp.
8,850,131
1
.0
47,202 
(1)
SpringWorks
Therapeutics,
Inc.
2,325,171
0
.3
134,131 
(1)
Tenet
Healthcare
Corp.
12,474,183
1
.5
53,324 
(1)
Vaxcyte,
Inc.
3,936,378
0
.5
31,625 
(1)
Vericel
Corp.
1,444,630
0
.2
92,045 
(1)
Viking
Therapeutics,
Inc.
7,092,067
0
.8
159,036,875
18
.6
Industrials
:
15
.8
%
23,795 
(1)
CACI
International,
Inc.
- Class
A
8,919,556
1
.0
121,358 
(1)
Casella
Waste
Systems,
Inc.
- Class
A
10,934,356
1
.3
70,712 
(1)
Chart
Industries,
Inc.
10,101,916
1
.2
54,070 
(1)
Clean
Harbors,
Inc.
9,846,147
1
.1
217,077 
(1)
Construction
Partners,
Inc.
- Class
A
10,437,062
1
.2
205,298 
Flowserve
Corp.
8,688,211
1
.0
259,731 
FTAI
Aviation
Ltd.
14,620,258
1
.7
97,739 
(1)
Kirby
Corp.
8,573,665
1
.0
259,247 
Marten
Transport
Ltd.
4,886,806
0
.6
70,533 
(1)
MYR
Group,
Inc.
11,458,791
1
.3
73,844 
(1)
NV5
Global,
Inc.
7,510,673
0
.9
18,863 
(1)
Saia,
Inc.
10,853,770
1
.3
121,560 
(1)
Trex
Co.,
Inc.
11,154,346
1
.3
186,877 
Werner
Enterprises,
Inc.
7,501,243
0
.9
135,486,800
15
.8
Information
Technology
:
31
.5
%
166,825 
(1)
Agilysys,
Inc.
12,978,985
1
.5
936,635 
(1)
Applied
Digital
Corp.
3,887,035
0
.4
35,238 
(1)
Axcelis
Technologies,
Inc.
3,970,265
0
.5
PORTFOLIO
OF
INVESTMENTS
as
of
February
29,
2024
(Unaudited)
(continued)
2
Voya
Small
Cap
Growth
Fund
Shares
Value
Percentage
of
Net
Assets
COMMON
STOCK:
(continued)
Information
Technology:
(continued)
417,030 
(1)
Clearwater
Analytics
Holdings,
Inc.
- Class
A
$
7,181,257
0
.8
338,528 
(1)
Couchbase,
Inc.
9,505,866
1
.1
34,361 
(1)
CyberArk
Software
Ltd.
9,063,057
1
.1
451,517 
(1)
ExlService
Holdings,
Inc.
14,051,209
1
.6
151,294 
(1)
FormFactor,
Inc.
6,510,181
0
.8
52,606 
(1)
Globant
SA
11,740,081
1
.4
100,331 
(1)
Guidewire
Software,
Inc.
11,973,502
1
.4
217,604 
Kulicke
&
Soffa
Industries,
Inc.
10,362,302
1
.2
48,745 
Littelfuse,
Inc.
11,613,009
1
.4
75,439 
Maximus,
Inc.
6,311,227
0
.7
136,038 
Napco
Security
Technologies,
Inc.
6,125,791
0
.7
49,035 
(1)
Onto
Innovation,
Inc.
9,030,286
1
.1
109,184 
Power
Integrations,
Inc.
7,802,289
0
.9
199,126 
(1)
Rambus,
Inc.
11,796,224
1
.4
242,304 
(1)
SentinelOne,
Inc.
- Class
A
6,825,704
0
.8
153,179 
Silicon
Motion
Technology
Corp.,
ADR
10,843,541
1
.3
103,284 
(1)
SiTime
Corp.
9,553,770
1
.1
190,059 
(1)
Smartsheet,
Inc.
- Class
A
8,022,390
0
.9
182,823 
(1)
Sprout
Social,
Inc.
- Class
A
11,302,118
1
.3
22,605 
(1)
Super
Micro
Computer,
Inc.
19,578,643
2
.3
244,581 
(1)
Tenable
Holdings,
Inc.
11,779,021
1
.4
435,918 
(1)
Tower
Semiconductor
Ltd.
14,332,984
1
.7
70,435 
Universal
Display
Corp.
12,285,273
1
.4
306,405 
(1)
Veeco
Instruments,
Inc.
11,094,925
1
.3
269,520,935
31
.5
Materials
:
4
.8
%
385,417 
(1)
Aspen
Aerogels,
Inc.
6,621,464
0
.8
131,206 
HB
Fuller
Co.
10,434,813
1
.2
73,036 
Innospec,
Inc.
9,076,184
1
.1
342,165 
(1)
Summit
Materials,
Inc.
- Class
A
14,613,867
1
.7
40,746,328
4
.8
Total
Common
Stock
(Cost
$638,374,047)
820,548,481
95
.8
Shares
Value
Percentage
of
Net
Assets
EXCHANGE-TRADED
FUNDS
:
1
.5
%
132,973 
SPDR
S&P
Biotech
ETF
$
13,087,202
1
.5
Total
Exchange-Traded
Funds
(Cost
$10,049,859)
13,087,202
1
.5
Total
Long-Term
Investments
(Cost
$648,423,906)
833,635,683
97
.3
Shares
RA
Value
Percentage
of
Net
Assets
SHORT-TERM
INVESTMENTS
:
3
.0
%
Mutual
Funds
:
3
.0
%
25,258,000 
(2)
Goldman
Sachs
Financial
Square
Government
Fund,
Institutional
Class,
5.190%
(Cost
$25,258,000)
$
25,258,000
3
.0
Total
Short-Term
Investments
(Cost
$25,258,000)
25,258,000
3
.0
Total
Investments
in
Securities
(Cost
$673,681,906)
$
858,893,683
100
.3
Liabilities
in
Excess
of
Other
Assets
(
2,944,529
)
(0.3)
Net
Assets
$
855,949,154
100.0
ADR
American
Depositary
Receipt
(1)
Non-income
producing
security.
(2)
Rate
shown
is
the
7-day
yield
as
of
February
29,
2024.
PORTFOLIO
OF
INVESTMENTS
as
of
February
29,
2024
(Unaudited)
(continued)
3
Voya
Small
Cap
Growth
Fund
Fair
Value
Measurements
The
following
is
a
summary
of
the
fair
valuations
according
to
the
inputs
used
as
of
February
29,
2024
in
valuing
the
assets
and
liabilities:
Quoted
Prices
in
Active
Markets
for
Identical
Investments
(Level
1)
Significant
Other
Observable
Inputs
(Level
2)
Significant
Unobservable
Inputs
(Level
3)
Fair
Value
at
February
29,
2024
Asset
Table
Investments,
at
fair
value
Common
Stock*
$
820,548,481
$
—
$
—
$
820,548,481
Exchange-Traded
Funds
13,087,202
—
—
13,087,202
Short-Term
Investments
25,258,000
—
—
25,258,000
Total
Investments,
at
fair
value
$
858,893,683
$
—
$
—
$
858,893,683
*
For
further
breakdown
of
Common
Stock
by
sector,
please
refer
to
the
Portfolio
of
Investments.
Net
unrealized
appreciation
consisted
of:
Gross
Unrealized
Appreciation
$
194,324,619
Gross
Unrealized
Depreciation
(
9,112,842
)
Net
Unrealized
Appreciation
$
185,211,777